The first phase 3 randomised clinical trial of an investigational mRNAnorovirusvaccine will open across the UK within the next two weeks. Sponsored by Moderna, the trial evaluates the efficacy ...
A new vaccine provides hope for treating and even preventing the highly contagious and difficult-to-treat Clostridioides difficile infection, more commonly known as C. difficile or C. diff. In animal ...
Moderna doses first participant in phase 3 trial of mRNA norovirus vaccine, mRNA-1403: Cambridge, Massachusetts Thursday, October 3, 2024, 12:00 Hrs [IST] Moderna, Inc, a global l ...